The first stop for professional medicines advice

Supply

23 results

RelevanceNewest firstOldest firstTitle
Applied filters

Outsourcing of Storage or Preparation of ATIMPs Across Legal Boundaries

15 November 2022Guidance on the considerations for Pharmacy Clinical Trial Sites outsourcing activities involved in the delivery of ATIMPs

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Direction (PGDs) for in End of Life Care

Patient Group Directions (PGDs) and abortifacients

14 September 2020This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Prescribing available HRT products

28 April 2022Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Supply and/or administration of Controlled Drugs under a Patient Group Direction

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Understanding transcribing for medicines administration in healthcare

22 February 2022Transcribing is accurately copying medication details. It requires assessment and mitigation against identified risks in different settings.

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGD are not legal mechanism for the administration or supply of unlicensed medicines.